Literature DB >> 17537614

Protein kinase Cepsilon makes the life and death decision.

Alakananda Basu1, Usha Sivaprasad.   

Abstract

Cancer is caused by dysregulation in cellular signaling systems that control cell proliferation, differentiation and cell death. Protein kinase C (PKC), a family of serine/threonine kinases, plays an important role in the growth factor signal transduction pathway. PKCepsilon, however, is the only PKCepsilon isozyme that has been considered as an oncogene. It can contribute to malignancy by enhancing cell proliferation or by inhibiting cell death. This review focuses on how PKCepsilon collaborates with other signaling pathways, such as Ras/Raf/ERK and Akt, to regulate cell survival and cell death. We have also discussed how PKCepsilon mediates its antiapoptotic signal by altering the level or function of pro- and antiapoptotic Bcl-2 family members.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537614      PMCID: PMC1986651          DOI: 10.1016/j.cellsig.2007.04.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  138 in total

Review 1.  The Bcl-2 family: roles in cell survival and oncogenesis.

Authors:  Suzanne Cory; David C S Huang; Jerry M Adams
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

Review 2.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

3.  Constitutive presence of a catalytic fragment of protein kinase C epsilon in a small cell lung carcinoma cell line.

Authors:  G Baxter; E Oto; S Daniel-Issakani; B Strulovici
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

Review 4.  Protein kinase C.

Authors:  S Stabel; P J Parker
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

5.  Involvement of protein kinase C-epsilon in glucocorticoid-induced apoptosis in thymocytes.

Authors:  M Iwata; R Iseki; K Sato; Y Tozawa; Y Ohoka
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

6.  Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.

Authors:  Alun Thomas; Chris Pepper; Terry Hoy; Paul Bentley
Journal:  Leuk Lymphoma       Date:  2004-05

7.  Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase.

Authors:  Jianhua Feng; Jongsun Park; Peter Cron; Daniel Hess; Brian A Hemmings
Journal:  J Biol Chem       Date:  2004-07-15       Impact factor: 5.157

Review 8.  Involvement of protein kinase C-delta in DNA damage-induced apoptosis.

Authors:  Alakananda Basu
Journal:  J Cell Mol Med       Date:  2003 Oct-Dec       Impact factor: 5.310

9.  Phorbol myristate induces apoptosis of taxol-resistant sarcoma cells in vitro.

Authors:  Zhi-ping Zong; Shinobu Matsui; Shogo Katsuda; Jian-feng Han; Kohzaburo Fujikawa-Yamamoto
Journal:  Eur J Pharmacol       Date:  2004-04-05       Impact factor: 4.432

10.  Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.

Authors:  Jae-Won Soh; Yun-Sil Lee; I Bernard Weinstein
Journal:  J Exp Ther Oncol       Date:  2003 May-Jun
View more
  68 in total

1.  Tribulosin protects rat hearts from ischemia/reperfusion injury.

Authors:  Shuang Zhang; Hong Li; Shi-jie Yang
Journal:  Acta Pharmacol Sin       Date:  2010-05-10       Impact factor: 6.150

Review 2.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

3.  Phorbol ester increases mitochondrial cholesterol content in NCI H295R cells.

Authors:  Wendy B Bollag; Patricia Kent; Stephanie White; Mariya V Wilson; Carlos M Isales; Roberto A Calle
Journal:  Mol Cell Endocrinol       Date:  2008-08-28       Impact factor: 4.102

4.  Oncogene PKCε controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.

Authors:  Suryakant K Niture; Averell Gnatt; Anil K Jaiswal
Journal:  J Cell Sci       Date:  2013-10-14       Impact factor: 5.285

5.  Specific subcellular targeting of PKCalpha and PKCepsilon in normal and tumoral lactotroph cells by PMA-mitogenic stimulus.

Authors:  Juan Pablo Petiti; Silvina Gutiérrez; Jorge Humberto Mukdsi; Ana Lucía De Paul; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2010-02-23       Impact factor: 2.611

6.  Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon.

Authors:  Sivalokanathan Sarveswaran; Vijayalakshmi Thamilselvan; Chaya Brodie; Jagadananda Ghosh
Journal:  Biochim Biophys Acta       Date:  2011-07-30

Review 7.  Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice.

Authors:  Michael Foster Olive; Philip M Newton
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

8.  Role of cPKCalpha and nPKCepsilon in EGF-stimulated goblet cell proliferation.

Authors:  Marie A Shatos; Robin R Hodges; Yoshia Oshi; Jeffrey A Bair; Driss Zoukhri; Claire Kublin; Kameran Lashkari; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

9.  Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2).

Authors:  M H Aziz; B B Hafeez; J M Sand; D B Pierce; S W Aziz; N E Dreckschmidt; A K Verma
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

10.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.